Funded Tech Companies
Sibylla Biotech
Sibylla Biotech, based in Adige, received equity investments from Indaco Venture Partners, V-Bio Ventures and VI Partners.
Company Overview
Company Name
Sibylla Biotech
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Via Sommarive, 9, Trento, Trentino-Alto
Adige, 38123
IT
Adige, 38123
IT
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
At Sibylla Biotech, we face the complexity of drug discovery with the power of an innovative approach for meeting unmet medical needs. Born out of a scientific challenge, the PPI-FIT protocol (Pharmacological Protein Inactivation by Folding Intermediates Targeting) leverages the enabling breakthrough of performing atomistic protein folding pathways simulations to unveil a new class of folding interfering degraders. Sibylla's drugs are small-molecule protein degraders, and PPI-FIT applies to any therapeutic area.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/4/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lidia Pieri
Co-Founder
Graziano Lolli
Co-Founder
Giovanni Spagnolli
Company Investors
- Indaco Venture Partners
- V-Bio Ventures
- VI Partners
- 3B Future Health Fund (Marianne Bjordal)
- Seroba Life Sciences (Bruno Montanari)
- Evolution Capital
- Claris Ventures (Ciro Spedaliere)
- CDP Venture Capital
- Vertis SGR
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs